Enhanced Histopathology of the Bone Marrow
Open Access
- 1 August 2006
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 34 (5) , 666-686
Abstract
Changes in bone marrow cellularity can be an indicator of systemic toxicity and, therefore, bone marrow should be included in the battery of tissues examined for enhanced histopathology. However, the majority of changes in the bone marrow that are observed in toxicology studies are a response to hematological changes or lesions elsewhere in the body. For this reason, a consideration of all tissue changes in the body is required in order to differentiate toxic effects versus physiological responses in the bone marrow. While enhanced histopathology involves evaluation of the separate compartments in each lymphoid organ using descriptive rather than interpretive terminology, bone marrow is unique in that it lacks specific compartments. Furthermore, identification of erythroid, myeloid, megakaryocytic, and stromal cells, plus adipose tissue and hemosiderin-laden macrophages, can be accomplished from conventional H&E-stained sections, but conclusive identification of lymphoid lineage cells is not likely. This limits the extent of initial enhanced histopathology on bone marrow and argues for the use of cytological preparations for more comprehensive assessment of potential immunomodulatory effects.Keywords
This publication has 4 references indexed in Scilit:
- Normal Structure, Function, and Histology of the Bone MarrowToxicologic Pathology, 2006
- STP Position Paper: Best Practice Guideline for the Routine Pathology Evaluation of the Immune SystemToxicologic Pathology, 2005
- Hematopoietic System2002
- Hemopoietic System1990